The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Open accessAbstract
Progression of fibrosis involves interstitial hypercellularity, matrix accumulation and atrophy of epithelial structures, resulting in the loss of normal function and ultimately organ failure. There is common agreement that the fibroblast/myofibroblast is the cell type most responsible for interstitial matrix accumulation and consequent structural deformations associated with fibrosis. During wound healing and progressive fibrotic events fibroblasts transform into myofibroblasts acquiring smooth muscle features, most notably the expression of alpha-smooth muscle actin (α-SMA) and synthesis of mesenchymal cell related matrix proteins. In renal disease, glomerular mesangial cells also acquire a myofibroblast phenotype and synthesize the same matrix proteins. The origin of interstitial myofibroblasts during fibrosis is a matter of debate where the cells are proposed to derive from resident fibroblasts, pericytes, perivascular adventitial, epithelial, and/or endothelial sources. Regardless of the origin of the cells, TGF-β1 is the principal growth factor responsible for myofibroblast differentiation to a profibrotic phenotype and exerts its effects via Smad signaling pathways involving MAPK and Akt/PKB. Additionally, reactive oxygen species (ROS) play important roles in progression of fibrosis. ROS are derived from a variety of enzyme sources of which the NAD(P)H oxidase family has been identified as a major source of superoxide and hydrogen peroxide generation in the cardiovasculature and the kidney during health and disease. Recent evidence indicates that the NAD(P)H oxidase homolog Nox4 is most accountable for ROS-induced fibroblast and mesangial cell activation where it has an essential role in TGF-β1 signaling of fibroblast activation and differentiation into a profibrotic myofibroblast phenotype and matrix production. Information on the role of ROS in mesangial cell and fibroblast signaling is incomplete and further research on myofibroblast differentiation during fibrosis is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–213 of 213
Ma, F. Y., Liu, J., Kitching, A. R., Manthey, C. L., & Nikolic‐Paterson, D. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90498.2008 · Cited by 50
Chai, D., Wang, B., Shen, L., Pu, J., Zhang, X.-K., & He, B. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.12.022 · Cited by 49
Kimura, M., Asano, M., Abe, K., et al. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh872 · Cited by 47
Induction and Progression of Cholangiofibrosis in Rat Liver Injured by Oral Administration of Furan
Hickling, K., Hitchcock, J. M., Chipman, J. K., Hammond, T. G., & Evans, J. G. (2010) · Toxicologic Pathology · doi:10.1177/0192623309357945 · Cited by 40
Renal Microvascular Injury in Diabetes: RAGE and Redox Signaling
Coughlan, M. T., Cooper, M. E., & Forbes, J. M. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.1469 · Cited by 39
Block, K. L., Ricono, J. M., Lee, D., Bhandari, B., Choudhury, G. G., Abboud, H. E., & Gorin, Y. C. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1497 · Cited by 35
Self-citationMitogenic Signaling via Platelet-Derived Growth Factor β in Metanephric Mesenchymal Cells
Wagner, B., Ricono, J. M., Gorin, Y. C., Block, K. L., Arar, M. Y., Riley, D., Choudhury, G. G., & Abboud, H. E. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006111229 · Cited by 34
Self-citationTong, X., & Schröder, K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.08.026 · Cited by 33
Li, Y., Lappas, G., & Anand‐Srivastava, M. B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01166.2006 · Cited by 31
A Rat Model of Progressive Chronic Renal Failure Produced by Microembolism
Kimura, M., Suzuki, T., & Hishida, A. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65239-x · Cited by 24
Barnes, V. L., Musa, J., Mitchell, R. J., & Barnes, J. L. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904700608 · Cited by 24
Self-citationCurrent Understanding of the Mechanism and Role of ROS in Angiotensin II Signal Transduction
Suzuki, H., Frank, G. D., Utsunomiya, H., Higuchi, S., & Eguchi, S. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106776597667 · Cited by 19
NADPH oxidase in the kidney: A Janus in determining cell fate
Jiang, F. (2008) · Kidney International · doi:10.1038/ki.2008.478 · Cited by 12
Cited by
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528
Cellular and molecular mechanisms of renal fibrosis
Liu, Y. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.149 · Cited by 1,446
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
Venkatachalam, M. A., Weinberg, J. M., Kriz, W., & Bidani, A. K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010006 · Cited by 744
Monteran, L., & Erez, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01835 · Cited by 675
Diabetes and Kidney Disease: Role of Oxidative Stress
Jha, J. C., Banal, C., Chow, B. S. M., Cooper, M. E., & Jandeleit-Dahm, K. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6664 · Cited by 660
Metadata
- Authors
- Barnes, J. L., & Gorin, Y.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2011-05
- Volume
- 79
- Issue
- 9
- Pages
- 944-956
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W1978593002
- Cited by
- 432
- References
- 213
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.